The US Food and Drug Administration said on Friday it was working rapidly to issue an emergency use authorisation for Pfizer's Covid-19 vaccine, with the first Americans set to be immunised as early as Monday or Tuesday. US Department of Health and Human Services Secretary Alex Azar said regulatory authorisation should come within days.
A panel of outside advisers to the FDA on Thursday voted overwhelmingly to endorse emergency use of the vaccine, paving the way for the agency to authorize the shot for a country that has lost more than 285,000 lives to Covid-19. Pfizer has asked the two-dose vaccine, developed with German partner BioNTech, be approved for use in people aged 16 to 85.
The agency has also notified the US Centers for Disease Control and Prevention and Operation Warp Speed so that it can execute the plans for timely vaccine distribution. The vaccine — shown to be 95% effective in preventing the disease — is already approved in Britain.
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU